What is the evidence for the use of Low Molecular Weight Heparins for the prophylaxis of travel-related thrombosis?

· UKMi

This Medicines Q&A evaluates the evidence for using low molecular weight heparins for the prevention of travel-related venous thromboembolism

Cardiovascular system disordersDalteparinEnoxaparinHaematological disordersParenteral AdministrationQ&ATinzaparinTravel Medicine

Attachments